BNP PARIBAS FINANCIAL MARKETS - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 92 filers reported holding SPERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15
-98.7%
12
-98.2%
0.00%
Q4 2022$1,156
-99.9%
668
+28.0%
0.00%
Q3 2022$1,044,000
-94.8%
522
-98.1%
0.00%
Q2 2022$20,137,000
-7.7%
27,176
+983.6%
0.00%
Q1 2022$21,820,000
-84.9%
2,508
-72.1%
0.00%
Q4 2021$144,042,000
+80.2%
8,997
+107.2%
0.00%
Q3 2021$79,955,000
+504.8%
4,343
+358.6%
0.00%
Q2 2021$13,220,000
-93.7%
947
-93.4%
0.00%
Q1 2021$210,923,000
+186.7%
14,329
+277.7%
0.00%
Q4 2020$73,566,000
+98.5%
3,794
+14.2%
0.00%
Q3 2020$37,062,000
+508.8%
3,321
+638.0%
0.00%
Q2 2020$6,088,000
-80.3%
450
-88.3%
0.00%
Q1 2020$30,979,000
+15.4%
3,834
+37.3%
0.00%
Q4 2019$26,845,000
+76.0%
2,792
+94.0%
0.00%
Q3 2019$15,253,000
-7.4%
1,439
+0.6%
0.00%
Q2 2019$16,471,000
-24.7%
1,431
-16.2%
0.00%
Q1 2019$21,867,000
+871.4%
1,707
+366.4%
0.00%
Q4 2018$2,251,000
-3.1%
366
+65.6%
0.00%
Q3 2018$2,323,000
-32.3%
221
-5.6%
0.00%
Q2 2018$3,433,000
-77.3%
234
-77.9%
0.00%
Q1 2018$15,119,000
+3.5%
1,061
-14.6%
0.00%
Q4 2017$14,605,0001,2430.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders